← Leaderboards
Alexander Aledo
Weill Medical College Of Cornell Univ
$128,106
Attributed
$128,106
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$128,106 · 1
By mechanism
M01$128,106 · 1
Top collaborators
No co-investigators on record.
Most similar at Weill Medical College Of Cornell Univ
Same institution · by research overlap
- Betty J. Casey$20,540,745
- David M. Nanus$4,374,762
- Maria I. New$8,913,834
- Francis Barany$10,854,311
- Michael P Wajnrajch$731,405
Others in their field
Top investigators on “Acute Lymphocytic Leukemia”
- Gregory H Reaman · National Childhood Cancer Foundation$49,776,131
- Markus Mãschen · Yale University$23,102,071
- Mary V. Relling · St. Jude Children'S Research Hospital$19,973,747
- John F Dipersio · Washington University$18,970,493
- William E. Evans · St. Jude Children'S Research Hospital$16,917,007
- Bruce R. Blazar · University Of Minnesota$16,394,527
Research focus
Acute Lymphocytic LeukemiaAdolescence (12-20)Bone Marrow TransplantationChild (0-11)Clinical ResearchCombination Cancer TherapyHuman SubjectHuman Therapy EvaluationImmunoconjugatesNeoplasm /Cancer Classification /StagingNeoplasm /Cancer ImmunotherapyPediatric Neoplasm /Cancer
Grant awards (3)
TREATMENT OF PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA WI/ UNFAVORABLE FEATURES$0
M01 · FY2002 · RR
TREATMENT OF PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA WI/ UNFAVORABLE FEATURES$0
M01 · FY2001 · RR
TREATMENT OF PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA WI/ UNFAVORABLE FEATURES$128,106
M01 · FY2000 · RR